As the parliamentary assistant to the Minister of Health, I’d like to introduce Cystic Fibrosis Canada to the Legislature today.

Cystic fibrosis is a progressive, degenerative, multi-system disease that affects mainly the lungs and digestive system, and it’s the most common fatal genetic disease, affecting 4,332 Canadian children and young adults.

Thank you for your work and your advocacy, Sasha, Jamie—and to all of you here today on behalf of CF. Welcome to Queen’s Park.

I’d like to welcome Kelly Grover and her team from Cystic Fibrosis Canada, who are here doing advocacy work on a very important cause.

I also want to recognize and welcome four of my constituents who are courageous advocates for CF: Jamie and Sasha Larocque, and Beth and Madi Vanstone.

Madi is living proof of the efficacy of Trikafta and how important that is and the work that we have to do to make that accessible.

I want to join with our friends here in thanking the people from Cystic Fibrosis Canada for that fantastic breakfast, for your amazing advocacy—and particularly to Ena Gaudet from Ottawa, thank you for all the great work you do with folks with CF in Ottawa. Thank you so much for being here.